Wolfe Reiterates on CVS Health (CVS): 'risk/reward for investors willing to look out 6-12 months while acknowledging NT pressures'
Tweet Send to a Friend
Wolfe Research analyst Justin Lake reiterated an Outperform rating and $80.00 price target on CVS Health (NYSE: CVS)The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
